Research Scientist – Nanoparticle & Bioconjugation Engineer (PhD Level)
PhD-level R&D / Research roles on Crosslinked list a median of $130k (154 that show pay).
Design and engineer nanoparticle constructs for biological delivery, diagnostics and therapeutics, with cell-based assay validation.
Weekly, free, one-click unsubscribe. Privacy
Worth knowing
Why it is interesting. Work on a novel intracellular nanoparticle delivery platform backed by Kleiner Perkins and DCVC, alongside renowned nanoscientist Paul Weiss.
Might not be for you. 50+ hour minimum in-person week and Bay Area residency required; no remote interviews.
Adjacent materials role:Nanoparticle design and development; gold and polymer nanoparticle engineering; polymer chemistry; oligonucleotide chemistry for drug-delivery nanoparticle constructs
Similar open roles
- Computational Scientist – Molecular Modeling & SimulationEli Lilly and Company · Indianapolis, IN $168k – $246k
- Associate Scientist, Sustainable Packaging MaterialsSeaSol Technologies, Inc. · Storrs, CT $55k – $65k
- Research ScientistPULPDENT Corporation · Watertown, MA $85k – $160k
- Seniority
- Mid-level
- Work
- On-site
- Type
- Full-time
- Degree
- PhD
- Industry
- Biotechnology
- Role
- R&D / Research
Role details
Must live in the SF Bay Area to apply, we will not interview anybody remotely
As a Research Scientist at Nanotrace, you will play a role in supporting projects critical to the development of our nanoparticle-based technology and developing it into research tools, diagnostics, and therapeutics. You will be a key team member in highly interdisciplinary, cutting-edge collaborative projects, working with a team of passionate and creative scientists and engineers. You will combine your knowledge in chemistry, reaction kinetics, thermodynamics, and biology with engineering principles to create nanoparticle constructs with never-before-seen capabilities in biological applications.
Education
PhD in Chemical Engineering, Biomedical Engineering, Biological engineering, or a related field with at least some background in biological applications.
Research Experience
Prior experience in Nanoparticle design and development for biological applications, either in academic or industry settings. Specifically gold and polymer nanoparticle engineering is a plus. Experience designing, executing, and troubleshooting mammalian cell-based assays. Therapeutic development is a plus, as well as surface patterning and fluorescence imaging. Experience in oligonucleotide chemistry, ASO development, and polymer chemistry a strong plus.
Soft Skills
Ability to work in a fast-paced, collaborative environment, and to communicate scientific findings effectively. A passion for creative and collaborative problem solving, growth mindset, and interest in tackling new skills as the scientific needs call for them.
Schedule
Full-time (5 0hrs a week minimum, in-person )
Location
Lab based in San Francisco, Dogpatch area, https://maps.app.goo.gl/KgoN7CJv4ppHrehEA
Salary
$100K – $125K + Equity
Why Join Us?
- Be part of an innovative startup working at the forefront of nanomedicine.
- Work next to some of the most brilliant minds in chemistry and nanomedicine.
- Gain hands-on experience in advanced nanoparticle research and biotechnology.
- Work alongside a team of experienced scientists dedicated to solving complex challenges at the interface of biology, chemistry, and chemical engineering.
About Nanotrace, Inc.
Nanotrace, Inc. is a stealth-mode biotech based in San Francisco, backed by Kleiner Perkins, DCVC, and many others. We are pioneering a breakthrough nanoparticle delivery technology designed to carry out pre-programmed functions within cells, namely detecting cancer biomarkers and delivering therapeutic drugs. Our mission is to validate this cutting-edge approach in animal models, operating in a fast-paced, high-risk, high-reward environment. As a small and agile team with decades of combined scientific expertise, we move quickly to generate results and overcome challenges.
Nanotrace is founded by Dr. Will Briley, PhD Molecular Biology from Northwestern; Dr. Paul Weiss, renowned nanoscientist, distinguished UCLA professor, and a UC Presidential Chair; David Spector, an experienced founder and formerly a Partner at Sequoia Capital, Google, and MIT; and, Chief Medical Advisor, Dr. Krishna Komanduri, Department Chief & Head of Hematology & Oncology, UCSF, and Clinical Director of the UCSF Living Therapeutics Initiative. Scientific advisory board (SAB) and partners include experts from MIT, Harvard, UCLA, Columbia, Memorial Sloan Kettering, ZEISS microscopy, and The Langer Lab.
